Latest GM & Biosafety Resources

Press Release Ouagadougou, August 22, 2025 Target Malaria is a research consortium led by Imperial College London, which receives core funding from the Bill and Melinda Gates Foundation to apparently eradicate malaria in Africa. The first phase of its project in Burkina Faso has been a dismal failure, involving the release of GM mosquitoes. We […]

Will stringent regulation safeguard Africa’s food systems? Across Africa, powerful corporate, donor, and government interests are driving a rapid push to deregulate genome editing in agriculture. Countries including Nigeria, Kenya, Ghana, Malawi, Ethiopia, and Burkina Faso have adopted product-based guidelines that exempt many genome-edited crops from GMO regulation if no foreign DNA is present in […]

This legacy series provides an opportunity to reflect on and celebrate the past two decades of ACB’s advocacy and activism, with a particular focus on resisting the introduction of genetically modified organisms (GMOs) into our agricultural and food systems in Africa.  Our first podcast in the series is hosted by ACB Research and Advocacy Officer […]

International and national biosafety regulations are urgently needed, including the right to say no By Sabrina Masinjila, African Centre for Biodiversity (ACB) research and advocacy officer Masinjila can be seen making a statement on behalf of the Convention of Biological Diversity Alliance (CBDA), calling for Parties to support the ongoing work of the Multidisciplinary Ad […]

Food sovereignty alliance from Latin America, Africa, and Asia approaches seven UN Special Rapporteurs for urgent intervention to block cultivation and trade of GM wheat HB4 To date over 100 organisations endorse this submission. Please note the deadline for endorsements is Wednesday 15 February. PRESS RELEASE 30 January 2024 On 26 January 2024, a submission […]

– By ACB Research and Advocacy Officer Sabrina Masinjila & Executive Director Mariam Mayet For several years, the ACB has engaged at multiple levels with the development of the Post-2020 Global Biodiversity Framework (GBF). In the lead up to the Convention on Biological Diversity (CBD) Conservation’s fifteenth Conference of Parties (COP 15), held in Montreal, Canada in […]

– A blog by ACB Director Mariam Mayet Snapshot In October 2021, the South African (SA) government determined that the regulatory and risk assessment framework that exists for genetically modified organisms (GMOs) will also apply to new breeding techniques (NBTs), which make up a host of new genetic engineering technologies. This decision appears to follow […]

(Veuillez cliquer ici pour lire en français) The African Centre for Biodiversity (ACB) hereby publishes a new research paper, titled, “The Financialisation of malaria: Burkina Faso, Rogue capital & GM/gene drive mosquitoes.” This paper seeks to understand the financialisation of malaria as a vehicle for rogue capital in a context of a weakened state (through […]

A coalition of non-governmental organisations, farmer groups and research experts from various African countries call on the Nigerian government to revoke the permits granted by Nigeria’s National Biosafety Management Agency (NBMA) to the Institute for Agricultural Research (IAR), Zaria, for the commercial release of genetically modified (Bt) Cowpea (PBR-Cowpea). This call was made yesterday in […]

In a totally unexpected move, the newly appointed Tanzania Agricultural Minister, Prof Adolf Mkenda, in mid-January 2021 announced the cancellation of research trials involving genetically modified organisms (GMOs) in the country and the decision to put in place extra biosafety scrutiny of imported genetically modified (GM) seed. The decision was taken by the Minister in […]

An unproven genetically modified (GM) RNAi cassava variety is yet another staple food crop, after maize and banana, on the biotech industry’s agenda for commercial cultivation in Kenya. The brazen lack of safety tests contained in the Kenya Agricultural and Livestock Research Organisation’s (KARLO’s) application for cultivation, and disregard for adherence to biosafety best practise […]

ACB brings you a new discussion paper Passer à la version française Clique aqui para a versão portuguesa Dear Friends and Colleagues, Expeditious and affordable access to medicines and other healthcare items will be critical to reducing the toll of COVID-19 in Africa. But if nothing is done to compel corporations to make their patents […]